Guido Dalbagni

23.4k total citations · 4 hit papers
276 papers, 15.3k citations indexed

About

Guido Dalbagni is a scholar working on Surgery, Urology and Oncology. According to data from OpenAlex, Guido Dalbagni has authored 276 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 251 papers in Surgery, 77 papers in Urology and 46 papers in Oncology. Recurrent topics in Guido Dalbagni's work include Bladder and Urothelial Cancer Treatments (234 papers), Urinary and Genital Oncology Studies (155 papers) and Urological Disorders and Treatments (66 papers). Guido Dalbagni is often cited by papers focused on Bladder and Urothelial Cancer Treatments (234 papers), Urinary and Genital Oncology Studies (155 papers) and Urological Disorders and Treatments (66 papers). Guido Dalbagni collaborates with scholars based in United States, Canada and Spain. Guido Dalbagni's co-authors include Harry W. Herr, Bernard H. Bochner, S. Machele Donat, Victor E. Reuter, Zuo‐Feng Zhang, Carlos Cordon‐Cardo, Shahrokh F. Shariat, Andrew J. Vickers, Paul Russo and Dean F. Bajorin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Guido Dalbagni

265 papers receiving 14.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology and Risk Factors of Urothelial Bladder Cancer

2012 1.5k citations Maximilian Burger, James W.F. Catto et al. European Urology profile →
Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

2008 1.0k citations Angel M. Cronin, Bernard H. Bochner et al. European Urology profile →
Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

2007 646 citations Guido Dalbagni, Raj S. Pruthi et al. profile →
Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

2014 401 citations Bernard H. Bochner, Guido Dalbagni et al. European Urology profile →

Peers

Countries citing papers authored by Guido Dalbagni

Since Specialization

Citations

This map shows the geographic impact of Guido Dalbagni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Dalbagni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Dalbagni more than expected).

Fields of papers citing papers by Guido Dalbagni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Dalbagni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Dalbagni. The network helps show where Guido Dalbagni may publish in the future.

Co-authorship network of co-authors of Guido Dalbagni

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Dalbagni. A scholar is included among the top collaborators of Guido Dalbagni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Dalbagni. Guido Dalbagni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract PR005: Final results from a Phase I trial of intravesical chemoimmunotherapy with gemcitabine and Bacillus Calmette-Guérin (BCG) for patients with BCG-exposed high-grade non-muscle invasive bladder cancer 2024 ·Clinical Cancer Research ·(unknown), Christopher Gaffney, Jessica A. Lavery, (unknown), (unknown), (unknown), (unknown), Patricia Morán, (unknown), (unknown), Daniel D. Sjoberg, Guido Dalbagni, Timothy R. Donahue, S. Machele Donat, Dean F. Bajorin, Bernard H. Bochner, Alvin C. Goh, Judy Sarungbam, Hikmat Al‐Ahmadie, Eugene J. Pietzak	0
2	Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma 2021 ·British Journal of Cancer ·Min Yuen Teo, Hikmat Al‐Ahmadie, Kenneth Seier, (unknown), Ashley Marie Regazzi, Eugene J. Pietzak, David B. Solit, Satish K. Tickoo, Victor E. Reuter, K. Eugene, Harry W. Herr, Timothy F. Donahue, S. Machele Donat, Guido Dalbagni, Bernard H. Bochner, Samuel A. Funt, Gopa Iyer, Dean F. Bajorin, Irina Ostrovnaya, Jonathan E. Rosenberg	21
3	Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer 2021 ·Clinical Cancer Research ·Jeffrey S. Damrauer, Kyle R. Roell, (unknown), Xuezheng Sun, Erin L. Kirk, Katherine A. Hoadley, Halei C. Benefield, Gopa Iyer, David B. Solit, Matthew I. Milowsky, William Y. Kim, Matthew E. Nielsen, Sara E. Wobker, Guido Dalbagni, Hikmat Al‐Ahmadie, Andrew F. Olshan, Bernard H. Bochner, Helena Furberg, Melissa A. Troester, Eugene J. Pietzak	33
4	Prospective Phase II Study to Evaluate Response to Two Induction Courses (12 intravesical instillations) of BCG Therapy for High-risk Non–muscle-invasive Bladder Cancer 2021 ·Urology ·Harry W. Herr, Emily Vertosick, Guido Dalbagni, K. Eugene, Robert P. Smith, Nicole Benfante, Daniel D. Sjoberg, John P. Sfakianos	3
5	Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience 2020 ·Clinical Genitourinary Cancer ·Gopa Iyer, (unknown), Emily C. Zabor, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr, (unknown), Paul Russo, Irina Ostrovnaya, Ashley Marie Regazzi, Matthew I. Milowsky, Jonathan E. Rosenberg, Dean F. Bajorin	28
6	Implementing a Multimodal Prehabilitation Program to Radical Cystectomy in a Comprehensive Cancer Center: A Pilot Study to Assess Feasibility and Outcomes 2019 ·Urologic Nursing ·Bente Thoft Jensen, Jørgen Bjerggaard Jensen, (unknown), (unknown), (unknown), Guido Dalbagni	15
7	Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma 2018 ·Human Pathology ·Sumit Isharwal, (unknown), Gouri J. Nanjangud, François Audenet, Ying‐Bei Chen, Anuradha Gopalan, Samson W. Fine, Satish K. Tickoo, Byron Lee, Gopa Iyer, Kalyani Chadalavada, Jonathan E. Rosenberg, Dean F. Bajorin, Harry W. Herr, S. Machele Donat, Guido Dalbagni, Bernard H. Bochner, David B. Solit, Victor E. Reuter, Hikmat Al‐Ahmadie	32
8	Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063) 2017 ·Bladder Cancer ·Guido Dalbagni, Nicole Benfante, Daniel D. Sjoberg, Bernard H. Bochner, S. Machele Donat, Harry W. Herr, (unknown), (unknown), (unknown), Jonathan E. Rosenberg, Dean F. Bajorin	17
9	The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4 cm 2016 ·Urologic Oncology Seminars and Original Investigations ·Roy Mano, Emily Vertosick, A. Ari Hakimi, Itay Sternberg, Daniel D. Sjoberg, Melanie Bernstein, Guido Dalbagni, Jonathan Coleman, Paul Russo	22
10	Management of Bladder Cancer After Renal Transplantation 2013 ·Urology ·Derek Prabharasuth, Kelvin A. Moses, Melanie Bernstein, Guido Dalbagni, Harry W. Herr	30
11	Epidemiology and Risk Factors of Urothelial Bladder Cancer breakdown → 2012 ·European Urology ·Maximilian Burger, James W.F. Catto, Guido Dalbagni, H. Barton Grossman, Harry W. Herr, Pierre I. Karakiewicz, Wassim Kassouf, Lambertus A. Kiemeney, Carlo La Vecchia, Shahrokh F. Shariat, Yair Lotan	1526
12	Prospective evaluation of MRI, 11C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer 2012 ·European Journal of Radiology ·Hebert Alberto Vargas, Oğuz Akın, Heiko Schöder, Semra Olgac, Guido Dalbagni, Hedvig Hricak, Bernard H. Bochner	52
13	Clinical benefits of a multivariate prediction model for bladder cancer 2009 ·Cancer ·Andrew J. Vickers, Angel M. Cronin, Michael W. Kattan, Mithat Gönen, Peter T. Scardino, Matthew I. Milowsky, Guido Dalbagni, Bernard H. Bochner	27
14	Comparison of bladder cancer survival among Japanese, Chinese, Filipino, Hawaiian and Caucasian populations in the United States. 2003 ·PubMed ·Mia Hashibe, (unknown), (unknown), Guido Dalbagni, Zuo‐Feng Zhang	13
15	Overview of bladder cancer trials in the Cancer and Leukemia Group B 2003 ·Cancer ·Eric J. Small, Susan Halabi, Guido Dalbagni, Raj S. Pruthi, (unknown), Martin J. Edelman, Dean F. Bajorin	29
16	CURRENT USE AND QUESTIONS CONCERNING INTRAVESICAL BLADDER CANCER GROUP FOR SUPERFICIAL BLADDER CANCER 2000 ·Urologic Clinics of North America ·Guido Dalbagni, Harry W. Herr	57
17	Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer 1996 ·International Journal of Cancer ·Louis Lacombe, Irene Orlow, Victor E. Reuter, William R. Fair, Guido Dalbagni, Zuo‐Feng Zhang, Carlos Cordon-Cardo	32
18	Clinical follow-up in 24 nonfamilial renal tumors cytogenetically characterized in tissue culture 1994 ·Urology ·Mircea Golimbu, Guido Dalbagni, John Provet, (unknown), Pablo Morales	2
19	Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease Progression 1993 ·JNCI Journal of the National Cancer Institute ·A. S. Sarkis, Guido Dalbagni, C. Cordon‐Cardo, Zuo‐Feng Zhang, Joel Sheinfeld, William R. Fair, H.W. Herr, Victor E. Reuter	437
20	Cell surface differentiation antigens of normal urothelium and bladder tumors 1992 ·Seminars in Surgical Oncology ·Guido Dalbagni, Victor E. Reuter, Joel Sheinfeld, Yves Fradet, William R. Fair, Carlos Cordon‐Cardo	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact